RE: American Pandemic Preparedness Plan update2 Sep 2022 17:42
Doc,
If the sp reaches my break-even price, I'll sell my full holding.
It is too dangerous holding now.
For example:
(1) Competitors such as Eiger who have BETTER DATA and are QUICKER to administer and CHEAPER.
(2) Politics. I suspect this is more important than the science.
If we don't get onto Strive, it's lights out in 24 months.
A lot of clever people have invested in this wonder drug over the years based on the amazing science.
However, look at the historical share price. It is sobering.
I hope we are successful and get onto Strive.
This has been a brutal lesson.